|
Dr. Woody brings more than 25 years of biomedical research and management experience to LVP. Dr. Woody was formerly President of Roche Bioscience in Palo Alto, CA where he had responsibility for all bioscience research and development, ranging from genetics and genomics to clinical development. Previously, Dr. Woody served as Chief Scientific Officer and Senior Vice President of R & D for Centocor, where he was responsible for the discovery and early clinical development of antibody and peptide-based therapeutic products. While at Centocor, Dr. Woody developed Remicade®, the first of the TNF inhibitor biologics, as well as ReoPro®, a novel platelet blocking drug used in conjunction with angioplasty. Prior to Centocor, Dr. Woody served as Commanding Officer and Director, US Naval Medical Research and Development Command in Bethesda Maryland. In that role, he was responsible for a wide range of medical research and development activities ranging from transplantation research to infectious diseases. He was responsible for the surveillance, detection and therapy for all Biologic Warfare Agents and Infectious Diseases in the first Gulf War, and was awarded the US Navy Legion of Merit for his service. Dr. Woody holds an M.D. from Loma Linda University, trained in Pediatric Immunology at Duke University and Children’s Hospital in Boston (Harvard), and holds a Ph.D. in Immunology from the University of London, England. | 